Skip to main content

Students in leadership positions learn about brain tumors and gain real world experience in running a non-profit business while raising funds for brain tumor research. Beneficiaries of the money we raise are Barrow Neurological Institute, National Brain Tumor Society, Phoenix Children's Hospital, Translational Genomics Research Institute, and University of Arizona.

"Be the change you wish to see in the world..." Gandhi

Our Beneficiaries

  • University of AZ Research Centers
    University of AZ Research Centers
  • “It is every man's obligation to put back into the world at least the equivalent of what he takes out of it.”

    — Albert Einstein

Brain Tumor Research News

University of Virginia School of Medicine researchers have developed a noninvasive way to remove faulty brain circuits that could allow doctors to treat debilitating neurological diseases without the need for conventional brain surgery.

Oligodendroglioma is a rare type of tumor found in the brain or spinal cord. Imaging tests such as magnetic resonance imaging (MRI) and computed tomography (CT) scans can detect an oligodendroglioma. A biopsy (sampling of tumor tissue) is required for an accurate diagnosis and to establish the grade of the tumor. This article discusses the options for diagnosing oligodendroglioma.

The team identified peptides that are unique to medulloblastoma tumors and then engineered T cells so they could recognize and target those proteins. The T cells eliminated medulloblastoma cells in test tubes.

That's why I was particularly excited to talk with neurosurgery chair Michael Lim, MD, for my latest article for Stanford Medicine magazine. We discussed recent advances in immunotherapy for brain tumors called glioblastomas. I learned that although immunotherapy has proven very effective for many cancer types, brain cancers are particularly challenging.

Doctors and scientists have successfully tested a neoantigen-specific transgenic immune cell therapy for malignant brain tumors for the first time using an experimental model in mice.

The technique uses light and nanoparticles to pry open temporarily these barriers — called tight junctions — to allow medication to reach its target.

View Previous News Articles - Click Here!